Therapeutics is a Swiss biotechnology start-up company
focusing on the development of novel combination
therapies, primarily for the use in oncology and
immuno-oncology. PreComb is developing a phenotypical
drug development platform using 3D microtissue culture
to enable high-throughput combinatorial drug screening.
The platform shall deliver more efficient cancer
therapies to substantially improve long-term prognosis
and quality-of-life for patients.